Acute kidney injury is frequently encountered in patients with malignancy and is associated with prolonged hospitalization, significant morbidity, and increased mortality. Thorough evaluation is required to identify possible contributing factors, which may range from relatively easily reversible pre-renal causes to complex cancer-specific aetiologies. This review will serve as a practical guide for acute care physicians on the acute medical unit to the assessment and initial management of cancer patients presenting with acute kidney injury.

[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]

References

1. Candrilli S, Bell T, Irish W, et al. A comparison of inpatient length of stay and costs among patients with hematologic malignancies (excluding Hodgkin disease) associated with and without acute renal failure. Clin Lymphoma Myeloma. 2008; 8: 44–51.
2. Darmon M, Ciroldi M, Thiery G, et al. Clinical review: specific aspects of acute renal failure in cancer patients. Crit Care. 2006; 10(2):211.
3. Christiansen CF, Johansen MB, Langeberg WJ, et al. Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study. Eur J Intern Med. 2011; 22(4):399-406.
4. Benoit DD, Hoste EA. Acute kidney injury in critically ill patients with cancer. Crit Care Clin. 2009; 26: 151–179.
5. Launay-Vacher V, Janus N, Deray G. Renal insufficiency and cancer treatments. ESMO Open. 2016;1(4):e000091.
6. Aapro M, Launay-Vacher V. Importance of monitoring renal function in patients with cancer. Cancer Treat Rev. 2012;38(3):235-40.
7. Cohen E, Krzesinski J-M, Launay-Vacher V, et al. Onco-Nephrology: Core Curriculum 2015. Am J Kidney Dis 2015; 66(5): 869-883.
8. Kitai Y, Matsubara T, Yanagita M. Onco-nephrology: current concepts and future perspectives. Japanese Journal of Clinical Oncology. 2015; 45(7):617-628.
9. Lahoti A, Humphreys BD. Chapter 3: AKI Associated with Malignancies. Onco-Nephrology Curriculum. American Society of Nephrology 2016.
10. Lam AQ, Humphreys BD. Onco-Nephrology: AKI in the Cancer Patient. Clin J Am Soc Nephrol 2012; 7: 1692-1700.
11. Campos MI, Campos CN, Aarestrup FM, et al. Oral mucositis in cancer treatment: Natural history, prevention and treatment. Mol Clin Oncol. 2014;2(3):337-340.
12. Bailey J, Shapiro MJ. Abdominal compartment syndrome. Crit Care. 2000;4(1):23-9.
13. Stewart AF: Clinical Practice. Hypercalcaemia associated with cancer. N Engl J Med. 2005; 352: 373-379.
14. Jhaveri KD, Shah HH, Patel C, et al. Glomerular diseases associated with cancer, chemotherapy, and hematopoietic stem cell transplantation. Adv Chronic Kidney Disease 2014; 21:48-55.
15. Lesesne JB, Rothschild N, Erickson B, et al. Cancer-associated haemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol 1989; 7:781-9.
16. Cohen LJ, Rennke HG, Laubach JP, et al. The spectrum of kidney involvement in lymphoma: A case report and review of the literature. Am J Kidney Dis. 2010; 56: 1191-1196.
17. Nephrology Secrets, 4th edition. Lerma, Sparks and Topf, 2018.
18. Abu-Alfa AK, Younes A. Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management. Am J Kidney Dis. 2010;55(5 Suppl 3):S1-13; quiz S14-9.
19. G. L. Jones, A. Will, G. H. Jackson, et al. The British Committee for Standards in Haematology, “Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology,” British Journal of Haematology, vol. 169, no. 5, pp.661–671, 2015.
20. Montseny JJ, Kleinknecht D, Meyrier A, et al. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Nephrol Dial Transplant. 1998; 13:1438-1445.
21. Hutchison CA, Cockwell P, Stringer S, et al. Early reduction of serum-free light chains associates with renal recovery in myeloma kidney. J Am Soc Nephrol 2011; 22: 1129-36.
22. Myeloma: diagnosis and management. NICE guidelines, 2016.
23. The Oxford Handbook of Nephrology and Hypertension, 2nd edition. Steddon and Ashman 2014.
24. Xu R, Tao A, Bai Y, Deng Y, et al. Effectiveness of N-Acetylcysteine for the Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2016;5(9).
25. Weisbord SD, Gallagher M, Jneid H, et al. Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med. 2018;378: 603–14.
26. Zager RA. Acute renal failure in the setting of bone marrow transplantation. Kidney Int 1994; 46: 1443-1458.
27. Lopes JA, Jorge S. Acute kidney injury following HCT: Incidence, risk factors and outcome. Bone Marrow Transplant. 2011; 46: 1399-1408.
28. Quencer KB, Friedman T, Sheth R, et al. Tumor thrombus: incidence, imaging, prognosis and treatment. Cardiovasc Diagn Ther. 2017;7(Suppl 3):S165–S177.
29. Humphreys BD, Soiffer RJ, Magee CC. Renal failure associated with cancer and its treatment: an update. J Am Soc Nephrol. 2005; 16: 151-61.
30. Vaglio A, F. Maritati. Idiopathic Retroperitoneal Fibrosis. J Am Soc Nephrol. 2016; 27(7): p. 1880-9.
31. Scherer JS, Swidler MA. Decision-making in patients with cancer and kidney disease. Adv Chronic Kidney Dis. 2014;21(1):72-80.